Table 1 Demographic characteristics of the study population
From: Oral immunotherapy with peach juice in patients allergic to LTPs
Sex, male, n | 7 |
Age (mean and range), years | 25.5 (5–42) |
Clinical symptoms (anaphylaxis) | 24 (9 associated with a cofactor: 4 exercise and 5 NSAIDs) |
Specific IgE | n (%) | kU/La |
|---|---|---|
Pru p 3 | 24 (100) | 7.43 (0.40–100) |
Peach | 24 (100) | 6.77 (1.00–76.10) |
Green bean | 6 (25) | 3.44 (0.44–71.00) |
Almond | 8 (33) | 2.91 (0.41–7.57) |
Hazelnut | 10 (42) | 2.53 (0.62–16.30) |
Nut | 8 (33) | 16.00 (2.44–42.90) |
Peanut | 16 (67) | 1.50 (0.42–22.70) |
Lettuce | 6 (25) | 2.54 (0.58–20.00) |
Apple | 7 (29) | 2.64 (0.59–32.00) |
Chickpea | 2 (8) | 11.79 (3.28–20.30) |
Plum | 3 (12) | 3.23 (1.60–30.10) |
Lentil | 3 (12) | 1.26 (1.06–21.50) |
Sunflower pip | 3 (12) | 10.70 (8.00–10.88) |
Grape | 3 (12) | 2.28 (0.59–3.54) |
Wheal diameter prick-test LTP (mm)a | 7.75 (3.00–11.50) | |
Wheal diameter prick-by-prick Granini® juice (mm)a | 6.00 (3.50–11.00) | |
Prick-by-Prick Granini® juice dilutions at end point | 1/100 (6 patients) | |
1/10 (14 patients) | ||
1/1 (4 patients) | ||
Prior ALK-Abelló® peach SLIT, n (%) | 7 (29%) | |